Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Ultra Nasdaq Biotech Proshares (BIB)

51.01 -0.30 (-0.58%)

8/18/2017  4:00pm

Open:

51.20

Pre. Close:

51.31

High:

51.82

Low:

50.60

Volume:

205,380

Market Cap:

N/A

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

52.2 - 52.94

52.94 - 53.47

Low:

48.44 - 49.55

49.55 - 50.35

Close:

49.5 - 51.12

51.12 - 52.3

Technical analysis  (as of: 2017-08-18 4:35:27 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 66.02     One year: 70.30

Support:

Support1: 50.60    Support2: 42.10

Resistance:

Resistance1: 56.53    Resistance2: 60.19

Pivot:

53.75

Moving Averages:

MA(5): 52.24     MA(20): 54.84

MA(100): 50.90     MA(250): 47.49

MACD:

MACD(12,26): -0.84     Signal(12,26,9): -0.29

%K %D:

%K(14,3): 10.59     %D(3): 15.56

RSI:

RSI(14): 37.74

52-Week:

High: 60.19  Low: 35.00  Change(%): -0.2

Average Vol(K):

3-Month: 30695  10-Days 10625

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
BIB has closed above bottom band by 11.0%. Bollinger Bands are 22.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 16 Jun 2010 00:47:34 GMT
ProShares UltraShort Nasdaq Biotechnology

Mon, 21 Dec 2015 12:59:12 GMT
How Prices Of ETF BIB Are Seen By Market-Makers

Wed, 07 Oct 2015 17:27:07 GMT
Only 9% Of Nasdaq Biotechnology Stocks Are Good Value: I Am Shorting The ...

Tue, 23 Jun 2015 16:43:30 GMT
More Triple-Leveraged Biotech ETFs Come to Town

Thu, 17 Aug 2017 19:07:30 GMT
ProShares Ultra Nasdaq Biotechnology (BIB) Declines 2.9% for Aug 17

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Financials

Industry:  Exchange Traded Funds

Shares Out. (M)

Shares Float (M)

% Held by Insiders

% Held by Institutions

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

Return on Equity (ttm)

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

FoxReading.com

Valuation

P/E

P/E Growth Ratio

P/BV

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.